To assess the effects of systemic therapies on the prevention or management of AIMSS in patients with Stage I-III hormone receptor-positive breast cancer.
This is a protocol.
Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer
You may also be interested in:
- Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer
- Bone-modifying agents for the prevention of bone loss in women with early or locally advanced breast cancer: a systematic review and network meta-analysis
- Prophylactic colony-stimulating factors to prevent infectious complications in patients with breast cancer undergoing chemotherapy
- Chinese medicinal herbs for the treatment of side-effects from chemotherapy in breast cancer patients
- Fibrin glue instillation under skin flaps to prevent seroma-related morbidity following breast and axillary surgery
Health topics: